Rock Springs Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,665
Closed -$3.37M 149
2018
Q3
$3.37M Hold
17,665
0.12% 128
2018
Q2
$2.94M Hold
17,665
0.11% 129
2018
Q1
$2.97M Buy
+17,665
New +$2.96M 0.13% 134
2017
Q3
Sell
-155,900
Closed -$37.9M 161
2017
Q2
$37.9M Sell
155,900
-10,100
-6% -$2.37M 1.91% 11
2017
Q1
$39.7M Hold
166,000
2.29% 7
2016
Q4
$34.9M Sell
166,000
-20,000
-11% -$4.14M 2.33% 7
2016
Q3
$42.8M Buy
186,000
+4,900
+3% +$1.2M 2.69% 6
2016
Q2
$41.9M Buy
181,100
+10,100
+6% +$2.33M 3.1% 3
2016
Q1
$45.8M Buy
171,000
+9,000
+6% +$2.58M 3.84% 2
2015
Q4
$50.6M Buy
162,000
+36,000
+29% +$10.7M 3.84% 1
2015
Q3
$34.2M Buy
126,000
+4,500
+4% +$1.38M 2.78% 6
2015
Q2
$36.9M Buy
121,500
+9,000
+8% +$2.68M 2.69% 6
2015
Q1
$33.5M Buy
112,500
+24,500
+28% +$6.99M 3.13% 4
2014
Q4
$22.7M Buy
88,000
+250
+0.3% +$62.5K 2.65% 9
2014
Q3
$21.2M Buy
87,750
+22,000
+33% +$4.92M 3.28% 7
2014
Q2
$14.7M Buy
65,750
+9,500
+17% +$1.97M 2.63% 9
2014
Q1
$11.6M Buy
56,250
+31,750
+130% +$6.29M 2.67% 12
2013
Q4
$4.12M Buy
+24,500
New +$3.83M 1.47% 21

Other funds holding AGN

Rock Springs Capital Management's AGN Position: Q4 2018 in Review

Rock Springs Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 17,665 shares — an estimated $3.37M sold.

Rock Springs Capital Management first reported a position in AGN in Q4 2013 and held it in 18 quarters. The position peaked at $50.6M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Rock Springs Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Rock Springs Capital Management sold 17,665 Allergan plc shares in Q4 2018, an estimated $3.37M.
  • Rock Springs Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 18 quarters.
  • Rock Springs Capital Management's Allergan plc position peaked at $50.6M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Rock Springs Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.